The Serum Institute of India has signed a deal with Bangladesh on Thursday to buy 30 million doses of coronavirus vaccine. The deal is made to buy the AstraZeneca potential coronavirus vaccines developed by the British drugmaker. In the race of potential vaccine against coronavirus, AstraZeneca is considered as one of the most advanced. 

American scientists made corona vaccine, claims it very effective

The deal was signed in Dhaka. Bangladesh health minister Zahid Maleque said,"Whenever the vaccine is ready, the Serum Institute will give us 30 million doses in the first phase".  Bangladesh's drug maker Beximco Pharmaceuticals will be utilised to purchase 5 million doses per month. Minister added through this deal the country will be able to vaccinate 15 million people as two shots of vaccine are needed for every individual. 

West Bengal Hospital to start Phase II trial of Russia's COVID-19 vaccine on approval from DGCI

The government said it is in talks with he World Bank and Asian Development Bank, to secure funds for the vaccine. The last-stage trial of Sinovac Biotech vaccine in Bangladesh attains uncertainty stage as the government refused to meet the Chinese company's demand for co-funding. The Serum institute will produce more than a billion doses of a COVID-19 vaccine for global supply in partnership with AstraZeneca, the Gates Foundation and the Gavi vaccine alliance. The companies and governments around the world has signed deal with the Serum Institute for manufacture and supplying the vaccine. 

Oxford’s Covid-19 vaccine could be ready by December: Serum Institute CEO